Company News
Gujarat Themis Biosyn Rs 335 Crore Preferential Issue
Gujarat Themis Biosyn board approved preferential issue of 82.1 lakh shares at Rs 408 each to raise Rs 335 crore.
Promoter group entity Pharmaceutical Business Group (India) Limited will subscribe to
